Navigation Links
Omeros Responds to Misleading Announcement by Davis Wright Tremaine Concerning Settlement with Former Chief Financial Officer
Date:11/9/2012

SEATTLE, Nov. 9, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today is addressing misleading statements in a press release issued yesterday by Davis Wright Tremaine, the law firm representing Richard J. Klein, Omeros' former chief financial officer with whom Omeros recently settled a lawsuit regarding his employment with Omeros.  Omeros' reasoned decision to enter into the settlement agreement and focus on its business is explained in its Current Report on Form 8-K filed with the Securities and Exchange Commission on November 1, 2012.  The settlement involved the release of all parties' claims, including Mr. Klein's claim to all Davis Wright Tremaine fees incurred since 2009. Omeros' insurance carrier has agreed to advance payment of the settlement funds subject to a reservation of rights.

Mr. Klein's employment with Omeros was terminated in January 2009. In September 2009, five days following Omeros' public filing of its intent to market its initial public offering, Thomas A. Lemly, partner at Davis Wright Tremaine, filed Mr. Klein's initial complaint alleging wrongful termination in retaliation for his whistleblow in connection with a grant awarded to Omeros by the National Institutes of Health (NIH). 

Omeros flatly denies that its termination of Mr. Klein's employment was retaliatory. Omeros believes that it had well-documented good cause to terminate Mr. Klein, including for his performance, as is detailed at length in the public record of this lawsuit.  Further, the evidentiary ruling by U.S. District Judge John C. Coughenour, cited in Davis Wright Tremaine's press release and issued well after the parties had commenced settlement negotiations, was a ruling on the admissibility of circumstantial evidence, which Omeros believed related only to claims that Judge Coughenour had previously dismissed, and not a finding of fact.

<
'/>"/>
SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 1, 2014  PTC Therapeutics, Inc. (NASDAQ: ... it approved non-statutory stock options to purchase an aggregate ... new employees. The awards were made pursuant to the ... new hires, employment compensation. The inducement grants ... 2014 and are being made as an inducement material ...
(Date:8/1/2014)... , Aug. 1, 2014  With monumental health reform ... speak a second language. Clinical efficacy is no longer ... under the ACA like PCORI are directing roughly $1 ... of new entities and environments, the federal healthcare ecosystem ... new language of outcomes and managed markets to the ...
(Date:8/1/2014)... and NEW YORK , ... VRX) and Pershing Square Capital Management, L.P. today responded ... Inc. (NYSE: AGN ) in California.  The ... regarding the tender offer rules.  Allergan,s ... to interfere with shareholders, efforts to call a special ...
Breaking Medicine Technology:PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 2Pharmaceuticals Learning the Language of the New Healthcare Landscape 2Pharmaceuticals Learning the Language of the New Healthcare Landscape 3Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 2Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 3Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 4Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 5Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 6
... International, Inc. (NYSE: VRX and ... to acquire certain assets from University Medical Pharmaceuticals ... products, for approximately $64 million plus potential milestones ... Medical,s main brand is AcneFree, a leading retail ...
... 3, 2012 New Report Added in ... and Forecasts, Worldwide, 2012 to 2018 ... Worldwide markets are poised to achieve significant growth as the ... to patients with chronic disease, decreasing hospitalizations and visits to ...
Cached Medicine Technology:Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical 2ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report 2ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report 3ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report 4ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report 5ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report 6ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report 7ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report 8
(Date:8/1/2014)... The successful development of C60F projects ... Guangdong FODAY Automobile Co.,LTD. As early as the very ... organized an excellent team to develop a comprehensive plan ... technical plans. The company’s vice president Liming Yang and ... involvement of the specific arrangement and the supervision of ...
(Date:8/1/2014)... 2014 Recently, iFitDress.com, one of the most ... assortment of top bridesmaid dresses online. At the ... prices, up to 52% off. According to the company’s senior ... August. , The company’s stock is limited. Those who ... online store as soon as possible. All its products are ...
(Date:8/1/2014)... 01, 2014 Cannabis use among young people ... 14 to 17 having used marijuana at least once and ... slogan “Say ‘No’ to Drugs, Say ‘Yes to Life,’ volunteers ... to youth this summer with factual information about drugs, to ... months, Hamburg “Say ‘No’ to Drugs, Say ‘Yes’ to Life,” ...
(Date:8/1/2014)... 01, 2014 The Judicial Panel on ... testosterone replacement therapy caused strokes, heart attacks, and other ... Judge Matthew F. Kennelly as the transferee judge and ... the Chicago-based federal court. , As one of his ... appointing committees of attorneys who will move the litigation ...
(Date:8/1/2014)... Researchers at the University of California, San Diego School ... ingredient in chili peppers produces chronic activation of ... triggering a reaction that ultimately reduces the risk of ... August 1, 2014 issue of The Journal of ... called TRPV1, was originally discovered in sensory neurons, where ...
Breaking Medicine News(10 mins):Health News:FODAY Automobile Company Is Now Working On The C60F FODAY Project 2Health News:iFitDress.com: Top Bridesmaid Dresses For The Global Customers 2Health News:Addressing a Serious Issue Affecting German Teens 2Health News:Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL 2Health News:Pepper and halt: Spicy chemical may inhibit gut tumors 2
... MDTH ) announced today that James E. Harris has ... become the Chief,Financial Officer for Charlotte, N.C. based Coca-Cola ... years, affiliation having,served on its Board of Directors and ... until near the end of January 2008, has been,with ...
... Allscripts, the leading,provider of clinical software, connectivity ... healthcare, today announced that the company,s,TouchWorks(TM) Electronic ... 1 product,in its market segment by the ... http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b ), TouchWorks earned the "Best ...
... Agency Adds 23 Clients in US, Europe and ... America,s largest and,fastest growing pay-for-placement public relations agency, ... businesses from South America to Asia.,The two-year old ... in a range of industries including financial services,healthcare, ...
... Officials, Legal Experts to Discuss Latest Criminal,Cases, Decrees and ... WASHINGTON, Dec. 20 In the last year,mainstream ... than $1.9,billion in fines, civil settlements and penalties. Top ... they did not,participate in or know about the crimes., ...
... ... heart disease patients, DETROIT, Dec. 20 Studies ... depression than those without heart,disease. The link between these two diseases ... heart patients is under-recognized and,even when diagnosed, under-treated., That,s why ...
... New Site Leadership Team at Cambridge Facility -, ... of its role as the global biologics unit ... D. Skibo has joined the company,as senior vice ... of the company, has been promoted to vice ...
Cached Medicine News:Health News:James E. Harris to Become Chief Financial Officer of Coca-Cola Bottling Co. Consolidated 2Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 2Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 3Health News:PayPerClip Grows 370% in 2007 2Health News:Food and Drug Law Institute Sponsors Major Enforcement Conference 2Health News:Blue Cross Blue Shield of Michigan Foundation Funds Study Exploring Link between Heart Disease and Depression 2Health News:MedImmune Expands Scientific and Engineering Leadership 2Health News:MedImmune Expands Scientific and Engineering Leadership 3Health News:MedImmune Expands Scientific and Engineering Leadership 4Health News:MedImmune Expands Scientific and Engineering Leadership 5
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: